PHAXIAM Therapeutics【PHXM】銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

通貨

1.82

買値

1.792

売値

1.82

出来高

12,312

1.79 日の範囲 1.82

1.50 52 週間の範囲 3.81

時価総額

56.401M

前日終値

1.796

始値

1.816

時刻

1.82

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

11,188

発行済株式数

30,989,584

配当利回り

PER

-2.40

1 株当たり利益 (EPS)

-0.76

歳入

1.33M

純利益

-23.49M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.phaxiam.com

本社

Lyon, Rhone, Fra

設立

PHAXIAM Therapeutics SA is listed in the Pharmaceutical Preparations sector of the ユーロネクスト with ticker PHXM. The last closing price for PHAXIAM Therapeutics was 1.80 €. Over the last year, PHAXIAM Therapeutics shares have traded in a share price range of 1.50 € to 3.81 €.

PHAXIAM Therapeutics currently has 30,989,584 shares in issue. The market capitalisation of PHAXIAM Therapeutics is 55.66 € million. PHAXIAM Therapeutics has a price to earnings ratio (PE ratio) of -2.40.

PHAXIAM Provides An Update On The Deployment Of Its Strategy To Maximize The Development Potential Of Phage Therapy

Strategy built around two complementary development axes: GMP Individualized Phage Therapies (IPT) and Phage Therapies Medicinal Products (PTMP), to maximize access to phage therapy care...

PHAXIAM Therapeutics and Technophage Enter Strategic Collaboration On Individualized GMP Phages Therapies (IPT) Against Bacteria Responsible For ~ 70%(1) Of The Most Common Severe Resistant Infections

Combined 25 GMP(2) Phages Portfolio to cover by end 2025 five of the most critical pathogens (S. aureus, P. aeruginosa, E. coli, K. pneumoniae, A. baumannii) and expansion by end 2026 to 35-45...

PHAXIAM Therapeutics Announces Its Financial Calendar for 2025

Regulatory News: PHAXIAM Therapeutics (Euronext: PHXM – FR0011471135), a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today announces...

PHAXIAM Therapeutics Announces Updated Real-Life Clinical Data From Patients Treated Under the Compassionate Status in Europe

Promising clinical results observed in the first 88 patients evaluated so far, confirming the safety and an important clinical benefit for patients Control of the infection at 3 months for 79...

PHAXIAM : Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 décembre 2024

Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Regulatory News: PHAXIAM (Paris:PHXM) : Place de cotation : Euronext Paris (Compartiment C - Code ISIN : FR001400K4B1 –...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.03	1.67597765363	1.79	1.82	1.75	4378	1.79333208	DE
4	0.12	7.05882352941	1.7	1.828	1.68	6447	1.76252174	DE
12	0.052	2.94117647059	1.768	1.85	1.5	11188	1.69665764	DE
26	-0.13	-6.66666666667	1.95	2.145	1.5	10450	1.75261693	DE
52	-1.99	-52.2309711286	3.81	3.81	1.5	9007	2.11479184	DE
156	1.03	130.379746835	0.79	6	0.353	24615	1.2057092	DE
260	1.03	130.379746835	0.79	6	0.353	24615	1.2057092	DE

PHXM - Frequently Asked Questions (FAQ)

What is the current PHAXIAM Therapeutics share price?

The current share price of PHAXIAM Therapeutics is 1.82 €

How many PHAXIAM Therapeutics shares are in issue?

PHAXIAM Therapeutics has 30,989,584 shares in issue

What is the market cap of PHAXIAM Therapeutics?

The market capitalisation of PHAXIAM Therapeutics is EUR 55.66M

What is the 1 year trading range for PHAXIAM Therapeutics share price?

PHAXIAM Therapeutics has traded in the range of 1.50 € to 3.81 € during the past year

What is the PE ratio of PHAXIAM Therapeutics?

The price to earnings ratio of PHAXIAM Therapeutics is -2.4

What is the cash to sales ratio of PHAXIAM Therapeutics?

The cash to sales ratio of PHAXIAM Therapeutics is 42.52

What is the reporting currency for PHAXIAM Therapeutics?

PHAXIAM Therapeutics reports financial results in EUR

What is the latest annual turnover for PHAXIAM Therapeutics?

The latest annual turnover of PHAXIAM Therapeutics is EUR 1.33M

What is the latest annual profit for PHAXIAM Therapeutics?

The latest annual profit of PHAXIAM Therapeutics is EUR -23.49M

What is the registered address of PHAXIAM Therapeutics?

The registered address for PHAXIAM Therapeutics is 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008

What is the PHAXIAM Therapeutics website address?

The website address for PHAXIAM Therapeutics is www.phaxiam.com

Which industry sector does PHAXIAM Therapeutics operate in?

PHAXIAM Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
ALCYBCybergun	0.0002 € (100.00%)	63.2M
TUVDSBio UV Group DS	0.015 € (70.45%)	490.92k
CANDCandela Invest	1.70 € (70.00%)	42
BIODSBiosynex DS	0.07 € (39.44%)	55.52k
ALGTRGroupe Tera SA	4.10 € (25.77%)	17.71k
MLIMLImalliance	0.282 € (-27.32%)	1.5k
ALCARCarmat	0.822 € (-22.60%)	3.04M
MLOCTOctopus Biosafety	0.14 € (-21.35%)	18.55k
ALEXPOne Experience	0.386 € (-21.22%)	933
SNGSonagi	0.80 € (-20.00%)	800
ATOAtos SE	0.0023 € (4.55%)	608.11M
ALVERVergnet	0.0011 € (0.00%)	92.88M
ALCYBCybergun	0.0002 € (100.00%)	63.2M
BCPBanco Comercial Portugues SA	0.5054 € (0.04%)	32.95M
KPNKoninklijke KPN NV	3.491 € (-1.77%)	16.54M